Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 423.35M | 420.29M | 411.59M | 402.58M | 396.78M |
| Total Other Revenue | 26.92M | 26.92M | 26.57M | 24.48M | 22.58M |
| Total Revenue | 450.27M | 447.22M | 438.15M | 427.06M | 419.36M |
| Cost of Revenue | 444.91M | 457.83M | 464.27M | 447.64M | 434.03M |
| Gross Profit | 5.35M | -10.61M | -26.12M | -20.57M | -14.67M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 28.80M | 29.69M | 30.22M | 29.02M | 28.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 473.72M | 487.52M | 494.49M | 476.65M | 462.08M |
| Operating Income | -23.45M | -40.30M | -56.34M | -49.59M | -42.72M |
| Income Before Tax | -119.65M | -133.10M | -140.37M | -156.41M | -171.07M |
| Income Tax Expenses | 130.58M | 75.61M | 19.23M | -24.55M | -68.50M |
| Earnings from Continuing Operations | -250.23 | -208.71 | -159.61 | -131.86 | -102.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -250.23M | -208.71M | -159.61M | -131.86M | -102.57M |
| EBIT | -23.45M | -40.30M | -56.34M | -49.59M | -42.72M |
| EBITDA | -2.48M | -19.08M | -35.03M | -29.40M | -23.43M |
| EPS Basic | -0.34 | -0.29 | -0.23 | -0.19 | -0.15 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.11 | -0.10 | -0.08 |
| EPS Diluted | -0.34 | -0.29 | -0.23 | -0.19 | -0.15 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.11 | -0.10 | -0.08 |
| Average Basic Shares Outstanding | 2.84B | 2.80B | 2.75B | 2.75B | 2.75B |
| Average Diluted Shares Outstanding | 2.84B | 2.80B | 2.75B | 2.75B | 2.75B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |